The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Acne Vulgaris

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Acne Vulgaris


Psychiatry related information on Acne Vulgaris


High impact information on Acne Vulgaris


Chemical compound and disease context of Acne Vulgaris


Biological context of Acne Vulgaris


Anatomical context of Acne Vulgaris


Gene context of Acne Vulgaris


Analytical, diagnostic and therapeutic context of Acne Vulgaris


  1. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Elkayam, O., Levartovsky, D., Brautbar, C., Yaron, M., Burke, M., Vardinon, N., Caspi, D. Am. J. Med. (1998) [Pubmed]
  2. Dienogest. Foster, R.H., Wilde, M.I. Drugs (1998) [Pubmed]
  3. Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. Elkayam, O., Yaron, M., Caspi, D. Ann. Rheum. Dis. (1996) [Pubmed]
  4. Minocycline-induced hyperpigmentation. Hung, P.H., Caldwell, J.B., James, W.D. The Journal of family practice. (1995) [Pubmed]
  5. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. Schaffer, J.V., Davidson, D.M., McNiff, J.M., Bolognia, J.L. J. Am. Acad. Dermatol. (2001) [Pubmed]
  6. Hypersomnia associated with isotretinoin in a patient with recurrent major depressive disorder and acne vulgaris. Shehi, G.M., Bryson, W.J. Sleep. (2004) [Pubmed]
  7. Liposomal tretinoin for uncomplicated acne vulgaris. Schäfer-Korting, M., Korting, H.C., Ponce-Pöschl, E. The Clinical investigator. (1994) [Pubmed]
  8. Bilateral nasal bone osteophytosis associated with short-term oral isotretinoin therapy for cystic acne vulgaris. Novick, N.L., Lawson, W., Schwartz, I.S. Am. J. Med. (1984) [Pubmed]
  9. Topical alpha-tocotrienol supplementation inhibits lipid peroxidation but fails to mitigate increased transepidermal water loss after benzoyl peroxide treatment of human skin. Weber, S.U., Thiele, J.J., Han, N., Luu, C., Valacchi, G., Weber, S., Packer, L. Free Radic. Biol. Med. (2003) [Pubmed]
  10. Topical antibacterial therapy for acne vulgaris. Dreno, B. Drugs (2004) [Pubmed]
  11. Adapalene: a review of its use in the treatment of acne vulgaris. Waugh, J., Noble, S., Scott, L.J. Drugs (2004) [Pubmed]
  12. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin. Yu, Z., Sefton, J., Lew-Kaya, D., Walker, P., Yu, D., Tang-Liu, D.D. Clinical pharmacokinetics. (2003) [Pubmed]
  13. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. Crawford, W.W., Crawford, I.P., Stoughton, R.B., Cornell, R.C. J. Invest. Dermatol. (1979) [Pubmed]
  14. Direct analysis of resistance in the cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin. Bojar, R.A., Hittel, N., Cunliffe, W.J., Holland, K.T. Drugs (1995) [Pubmed]
  15. Skin surface glycerol levels in acne vulgaris. Rebillo, T., Hawk, J.L. J. Invest. Dermatol. (1978) [Pubmed]
  16. Tazarotene. Foster, R.H., Brogden, R.N., Benfield, P. Drugs (1998) [Pubmed]
  17. Vitamin A acid: a review of its pharmacological properties and therapeutic use in the topical treatment of acne vulgaris. Heel, R.C., Brogden, R.N., Speight, T.M., Avery, G.S. Drugs (1977) [Pubmed]
  18. Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Margolis, D.J., Attie, M., Leyden, J.J. Archives of dermatology. (1996) [Pubmed]
  19. The effect of long term tetracycline treatment for acne vulgaris on the occurrence of R factors in the intestinal flora of man. Valtonen, M.V., Valtonen, V.V., Salo, O.P., Mäkelä, P.H. Br. J. Dermatol. (1976) [Pubmed]
  20. Androgen levels in women using a single implant of nomegestrol acetate. Barbosa, I., Coutinho, E., Athayde, C., Ladipo, O.A., Olsson, S.E., Ulmsten, U. Contraception. (1996) [Pubmed]
  21. A general practice study investigating the effect of Minocin 50 mg b.d. for 12 weeks in the treatment of acne vulgaris. Cohen, P.M. J. Int. Med. Res. (1985) [Pubmed]
  22. Ophthalmological effects of 13-cis-retinoic acid therapy for acne vulgaris. Milson, J., Jones, D.H., King, K., Cunliffe, W.J. Br. J. Dermatol. (1982) [Pubmed]
  23. Black breast milk due to minocycline therapy. Hunt, M.J., Salisbury, E.L., Grace, J., Armati, R. Br. J. Dermatol. (1996) [Pubmed]
  24. Thyroid carcinoma and hyperparathyroidism after radiation therapy for adolescent acne vulgaris. De Jong, S.A., Demeter, J.G., Jarosz, H., Lawrence, A.M., Paloyan, E. Surgery (1991) [Pubmed]
  25. Steroid metabolism in human skin: its relation to sebaceous-gland growth and acne vulgaris. Hodgins, M.B., Hay, J.B. Biochem. Soc. Trans. (1976) [Pubmed]
  26. Erythrocyte glutathione peroxidase activity in acne vulgaris and the effect of selenium and vitamin E treatment. Michaëlsson, G., Edqvist, L.E. Acta Derm. Venereol. (1984) [Pubmed]
  27. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Kim, J. Dermatology (Basel) (2005) [Pubmed]
  28. Plasma androgenic activity in women with acne vulgaris and in healthy girls before, during and after puberty. Odlind, V., Carlström, K., Michaëlsson, G., Vahlqvist, A., Victor, A., Mellbin, T. Clin. Endocrinol. (Oxf) (1982) [Pubmed]
  29. Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris. Darley, C.R., Kirby, J.D., Besser, G.M., Munro, D.D., Edwards, C.R., Rees, L.H. Br. J. Dermatol. (1982) [Pubmed]
  30. Defensins and acne. Philpott, M.P. Mol. Immunol. (2003) [Pubmed]
  31. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris. Verschoore, M., Langner, A., Wolska, H., Jablonska, S., Czernielewski, J., Schaefer, H. Br. J. Dermatol. (1991) [Pubmed]
  32. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. Hongcharu, W., Taylor, C.R., Chang, Y., Aghassi, D., Suthamjariya, K., Anderson, R.R. J. Invest. Dermatol. (2000) [Pubmed]
  33. Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study. Gammon, W.R., Meyer, C., Lantis, S., Shenefelt, P., Reizner, G., Cripps, D.J. J. Am. Acad. Dermatol. (1986) [Pubmed]
  34. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Thiboutot, D., Gold, M.H., Jarratt, M.T., Kang, S., Kaplan, D.L., Millikan, L., Wolfe, J., Loesche, C., Baker, M. Cutis; cutaneous medicine for the practitioner. (2001) [Pubmed]
  35. Erythromycin 2 percent gel in the treatment of acne vulgaris. Pochi, P.E., Bagatell, F.K., Ellis, C.N., Stoughton, R.B., Whitmore, C.G., Saatjian, G.D., Sefton, J. Cutis; cutaneous medicine for the practitioner. (1988) [Pubmed]
WikiGenes - Universities